Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function

Documenti analoghi

• Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
  di: Chen, W, et al.
  Pubblicazione: (2018)
• Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
  di: Xue, L, et al.
  Pubblicazione: (2018)
• Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
  di: Sandham, D, et al.
  Pubblicazione: (2019)
• Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
  di: Xue, L, et al.
  Pubblicazione: (2019)
• Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells
  di: Luo, J, et al.
  Pubblicazione: (2019)